Ann Neurol
- LOW A, Gunter JL, Hu M, Raghavan S, et al
Perivascular Spaces as Determinants of Amyloid, Tau, and Vascular Biomarker
Progression.
Ann Neurol. 2026;100:695-708.
Ann Nucl Med
- BANALA M, Ezuddin S, Makanji R, Foley M, et al
From sensitivity gain to clinical decisions: total-body and
long-axial-field-of-view PET/CT for diagnosis and image-based management in
oncology and systemic disease.
Ann Nucl Med. 2026 Sep 14. doi: 10.1007/s12149-026-02282.
- AKSU A, Agartioglu AI, Guc ZG, Kucuker KA, et al
The anatomical distribution of metabolic tumor burden provides prognostic
information beyond whole-body (1)(8)F-FDG PET/CT metrics in de novo metastatic
HER2-positive breast cancer.
Ann Nucl Med. 2026 Sep 14. doi: 10.1007/s12149-026-02286.
Appl Radiat Isot
- TAHMASEBZADEH A, Ghafarian P, Sadeghi M
Deep learning-based approaches for attenuation correction in [(18)F]FDG PET:
Current advances and future directions.
Appl Radiat Isot. 2026;238:112934.
BMC Neurol
- HUANG Y, Zhou C, Liu R, Li W, et al
Mismatch-time ratio combined with ASPECTS: a novel indicator of favorable
prognosis in multimodal ct prediction of anterior circulation large vessel
occlusion.
BMC Neurol. 2026 Jun 29. doi: 10.1186/s12883-026-05113.
Brain
- SILVA LC, Oliveira FPM, Costa DC
Brain fluorodeoxyglucose PET anatomical segmentation via AI: extensive validation
in the neurodegenerative spectrum.
Brain. 2026 Sep 15:awag314. doi: 10.1093.
J Nucl Cardiol
- ROJULPOTE CS, Hankinson SJ, Carre S, Hainer J, et al
CMR and FDG PET/CT Imaging Phenotypes and their Association with Outcomes in
Patients with Known or Suspected Myocarditis.
J Nucl Cardiol. 2026 Sep 18:102968. doi: 10.1016/j.nuclcard.2026.102968.
J Nucl Med
- CROSBY M
Recurrence: A Patient's Perspective on How Nuclear Medicine Creates Hope Through
Clarity.
J Nucl Med. 2026 Sep 17:jnumed.126.273683. doi: 10.2967/jnumed.126.273683.
- KOMEK H, Arslan E, Can C, Akgun E, et al
From Metabolism to Molecular Phenotype: Carbonic Anhydrase IX-Targeted
[(68)Ga]Ga-DPI-4452 PET/CT in Renal Cell Carcinoma: A Prospective Multicenter
Comparison with [(18)F]FDG PET/CT.
J Nucl Med. 2026 Sep 17:jnumed.126.273011. doi: 10.2967/jnumed.126.273011.
- TOSATO M, Kleynhans J, van de Voorde M, Favaretto C, et al
Beta Atlas: Charting Global Production of Nonconventional beta(-)-Emitters for
Targeted Radiopharmaceutical Therapy-Part 1.
J Nucl Med. 2026 Sep 17:jnumed.126.272648. doi: 10.2967/jnumed.126.272648.
Nucl Med Commun
- DEMIRTAS SENLIK S, Noyaner Cinar A, Engur Uyanik CO, Erdem Karaoglu A, et al
Fluorodeoxyglucose PET/CT-derived Metabolic Peritoneal Cancer Index for survival
assessment in peritoneal carcinomatosis.
Nucl Med Commun. 2026 Sep 14. doi: 10.1097/MNM.0000000000002244.
Phys Med Biol
- MOLINER L, Correcher C, Beltra A, Molinos C, et al
Beyond NEMA: robustness, DOI encoding, and multi-mouse imaging performance of the
Bruker PET/CT Si78.
Phys Med Biol. 2026 Sep 16. doi: 10.1088/1361-6560.
- LEONTIOU T, Frixou A, Ttofi E, Chrysostomou C, et al
Hamiltonian dynamics for stochastic reconstruction in emission tomography.
Phys Med Biol. 2026;71.
Semin Nucl Med
- METRARD G, Mazet R, Bailly M
Parametric dynamic SPECT using a 3D CZT-ring camera for rapid characterization of
disseminated splenosis.
Semin Nucl Med. 2026 Sep 18:S0001-2998(26)00179.
- TORRICELLI C, Nogueira-Lima E, Etchebehere E
The value of (18)F-fluoride PET in bone metastases: an overview.
Semin Nucl Med. 2026 Sep 17:S0001-2998(26)00181.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016